J107-0616 Screening compound: N-(8-chloro-2,3,4,9-tetrahydro-1H-carbazol-1-yl)acetamide

J107-0616 Screening compound: N-(8-chloro-2,3,4,9-tetrahydro-1H-carbazol-1-yl)acetamide
J107-0616 Screening compound: N-(8-chloro-2,3,4,9-tetrahydro-1H-carbazol-1-yl)acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound J107-0616
N-(8-chloro-2,3,4,9-tetrahydro-1H-carbazol-1-yl)acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

J107-0616

Molecular Formula

C14H15ClN2O (C14 H15 ClN2 O)

Compound Name

N-(8-chloro-2,3,4,9-tetrahydro-1H-carbazol-1-yl)acetamide

IUPAC name

N-(8-chloro-2349-tetrahydro-1H-carbazol-1-yl)acetamide

SMILES

CC(NC(CCC1)c2c1c1cccc(Cl)c1[nH]2)=O

InChI

InChI=1S/C14H15ClN2O/c1-8(18)16-12-7-3-5-10-9-4-2-6-11(15)13(9)17-14(10)12/h2,4,6,12,17H,3,5,7H2,1H3,(H,16,18)/t12-/m0/s1

InChI Key

BGWVQDYSQKSWHW-LBPRGKRZSA-N

MDL Number (MFCD)

MFCD28051672

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

262.74

Hydrogen Bond Acceptors Count

2.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

2.00

Number of Nitrogen and Oxygen Atoms

3

Partition Coefficient, logP

2.749

Distribution Coefficient, logD

2.749

Water Solubility, LogSw

-3.31

Polar Surface Area

35.647

Acid Dissociation Constant (pKa)

12.19

Base Dissociation Constant (pKb)

-1.33

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

35.71

J107-0616 in Drug Discovery

Included in Screening Libraries

3D-Diversity Natural-Product-Like Library (18102 compounds)

3D-Fragment Library (4274 compounds)

DGK Inhibitors Library (10558 compounds)

Protein-Protein Interaction Library (218420 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Epitranscriptome Focused Small Molecule Library (20952 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
  • 3D
  • Fragments
  • Cyclic compounds
Therapeutical areas:
  • Cancer
  • Digestive system
  • Hemic and lymphatic
  • Skin
  • Metabolic
  • Immune system
  • Nervous system
  • Hemic and lymphatic
  • Congenital
  • Metabolic
Targets:
  • Kinases
Mechanism of action:
  • PPI modulators
  • Epigenetic

References: we are preparing a list of scientific research reports with J107-0616 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound J107-0616?
Check Price and Availability of J107-0616, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of J107-0616 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for J107-0616
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for J107-0616
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of J107-0616 available by request